TrialCancer prevention research (Philadelphia, Pa.)2016

Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers.

Jian-Min Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.